Monday, July 9, 2012

The FDA: In need of an innovation overhaul | UTSanDiego.com

I think we need a new approach to approving new drugs.  Here's a good editorial:

The FDA: In need of an innovation overhaul | UTSanDiego.com:

It seems to me that the FDA should be involved in protecting the safety of drugs -- but not the effectiveness of them.  The FDA could provide a "clearing house" for effectiveness of drugs, but allowing drug companies to submit their studies and tests to prove effectiveness.  Of course Government medical providers, such as Medicare will only look for those that are proven effective.  Likely that insurance will also.  However proving effectiveness is much more difficult than proving safety.

No comments:

Post a Comment